Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM, Mao L.
Kawaguchi H, et al. Among authors: lippman sm.
J Clin Oncol. 2008 Jan 20;26(3):354-60. doi: 10.1200/JCO.2007.13.4072.
J Clin Oncol. 2008.
PMID: 18202409